Shirooie, Samira, Nabavi, Seyed Fazel, Dehpour, Ahmad R., Belwal, Tarun, Habtemariam, Solomon, Argüelles, Sandro, Sureda, Antoni, Daglia, Maria, Tomczyk, Michał, Sobarzo-Sanchez, Eduardo, Xu, Suowen and Nabavi, Seyed Mohammad (2018) Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration? Pharmacological Research, 135. pp. 37-48. ISSN 1043-6618 (Print), 1096-1186 (Online) (doi:https://doi.org/10.1016/j.phrs.2018.07.004)

Full text not available from this repository. (Request a copy)

Abstract

Neurodegenerative diseases (NDs) such as Parkinson's (PD), Alzheimer's (AD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) cause significant world-wide morbidity and mortality. To date, there is no drug of cure for these, mostly age-related diseases, although approaches in delaying the pathology and/or giving patients some symptomatic relief have been adopted for the last few decades. Various studies in recent years have shown the beneficial effects of omega-3 poly unsaturated fatty acids (PUFAs) through diverse mechanisms including anti-inflammatory effects. This review now assesses the potential of this class of compounds in NDs therapy through specific action against the mammalian target of rapamycin (mTOR) signaling pathway. The role of mTOR in neurodegenerative diseases and targeted therapies by PUFAs are discussed.

Item Type:	Article
Uncontrolled Keywords:	Neurodegenerative diseases; mTOR; omega-3; Docosahexaenoic acid; Eicosapentaenoic acid
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science Faculty of Engineering & Science > School of Science (SCI)
Last Modified:	29 Nov 2018 17:34
URI:	http://gala.gre.ac.uk/id/eprint/22281

Actions (login required)

View Item